Clinical trial
Confirmatory Study of DSP-5423P in Patients With Schizophrenia
NCT02287584 is registered in ClinicalTrials.gov with Sumitomo Pharma Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Confirmatory Study of DSP-5423P in Patients With Schizophrenia
- Lead sponsor
- Sumitomo Pharma Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2014
- Completion date
- December 31, 2018
- Enrollment
- 580 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.